pubmed-article:8611645 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0085262 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0026377 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0037633 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0597486 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C1382100 | lld:lifeskim |
pubmed-article:8611645 | lifeskim:mentions | umls-concept:C0599956 | lld:lifeskim |
pubmed-article:8611645 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8611645 | pubmed:dateCreated | 1996-6-4 | lld:pubmed |
pubmed-article:8611645 | pubmed:abstractText | The secondary structures of peptides beta 25-35 (the active toxic fragment) and beta 35-25 (reverse sequence and non-toxic fragment), as well as of the amidated beta (25-35)-NH2 peptide were investigated in aqueous solution and in the solid state by means of Fourier-transformed infrared spectroscopy and circular dichroism spectroscopy. The conformations of the beta 25-35 and beta 35-25 in solid state were identical and contained mostly beta-sheet structures. In solid state the amidated beta (25-35)-NH2 peptide also contained mostly beta-sheet structures. Freshly prepared aqueous solutions of the beta 25-32 (0.5 - 3.8 mM) contained a mixture of beta-sheet and random coil structures. Within 30-60 min incubation at 37 degrees C in water or in phosphate-buffered saline solution (PBS), beta 25-35 was almost fully converted to a beta-sheet structure. Decreasing the temperature from 37 degrees C to 20 degrees C decreased the rate of conversion from random coil to beta-sheet structures, 1-2 h being required for complete conversion. In contrast beta 35-25 in water or in PBS buffer had mostly a random coil structure and remained so for 6 days. The amidated beta(25-35)-NH2 peptide in water (2.7 mM) was also mostly random coil. However, when this peptide (2-2.7 mM) was dissolved in PBS (pH 7.4) or in 140 mM NaCl, a gel was formed and its conformation was mostly beta-sheet. Decreasing the concentration of beta (25-35)-NH2 peptide in 140 mM NaCl aqueous solution from 2 mM to 1 mM or below favored the conversion from beta-sheet structures to random coil structures. The beta 25-35 was toxic to PC12 cells while beta 35-25 was not. The amidated peptide beta (25-35)-NH2 was at least 500-fold less toxic than beta 25-35. Structural differences between these beta peptides in aqueous solutions may explain the difference in their respective toxicities. | lld:pubmed |
pubmed-article:8611645 | pubmed:language | eng | lld:pubmed |
pubmed-article:8611645 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8611645 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8611645 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8611645 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8611645 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8611645 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8611645 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8611645 | pubmed:month | Jan | lld:pubmed |
pubmed-article:8611645 | pubmed:issn | 0006-3002 | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:FreyPP | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:SwobodaRR | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:OWENEE | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:BuchetRR | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:StaufenbielMM | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:de La... | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:TavitianEE | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:GremlichH UHU | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:RistigDD | lld:pubmed |
pubmed-article:8611645 | pubmed:author | pubmed-author:StaussUU | lld:pubmed |
pubmed-article:8611645 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8611645 | pubmed:day | 17 | lld:pubmed |
pubmed-article:8611645 | pubmed:volume | 1315 | lld:pubmed |
pubmed-article:8611645 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8611645 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8611645 | pubmed:pagination | 40-6 | lld:pubmed |
pubmed-article:8611645 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:meshHeading | pubmed-meshheading:8611645-... | lld:pubmed |
pubmed-article:8611645 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8611645 | pubmed:articleTitle | Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells. | lld:pubmed |
pubmed-article:8611645 | pubmed:affiliation | Sandoz Research Institute Berne Ltd, Switzerland. | lld:pubmed |
pubmed-article:8611645 | pubmed:publicationType | Journal Article | lld:pubmed |